Manzatin-E Diaper Rash Skin Protectant

Dosage form: ointment
Ingredients: ZINC OXIDE 18g in 100g
Labeler: Laboratorios Zepol S.A.
NDC code: 55715-002

Medically reviewed by Drugs.com. Last updated on Dec 18, 2023.

Manzatin-E Diaper Rash Skin Protectant

Active Ingredient

Zinc Oxide 18%

Purpose

Skin Protectant

Uses

Helps treat and prevent diaper rash. Protects chafed skin due to diaper rash and helps seal out wetness.

Warnings

For external use only.

When using this product

do not get into eyes

Stop using and ask a doctor if

-condition worsens
- symptoms last more than 7 days or clear up and occur again within a few days.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Change wet and soiled diapers promptly, cleanse the diaper area and allow to dry. Apply cream liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged.

Other Information

- Store in a fresh place,
preferably below 30 degrees C (86 degrees F).

Inactive Ingredients

Chamomile Flower Extract, CodmLiver Oil, in a special protective lipoid cream base, Corn Starch,

MANZATIN-E DIAPER RASH SKIN PROTECTANT
zinc oxide ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:55715-002
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (ZINC OXIDE)	ZINC OXIDE	18 g in 100 g

Inactive Ingredients
Ingredient Name	Strength
CHAMOMILE
COD LIVER OIL
STARCH, CORN

Packaging
#	Item Code	Package Description
1	NDC:55715-002-02	90 g in 1 TUBE
2	NDC:55715-002-06	1 TUBE in 1 BOX
2		180 g in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part348	10/01/2009

Labeler - Laboratorios Zepol S.A. (853070985)

Document Id: 6195e63c-01f6-6c90-e053-2991aa0ae81a

Set id: cafd084f-8493-4d6e-b256-2d4b4282f866

Version: 5

Effective Time: 20171227

Laboratorios Zepol S.A.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Psoriasis 101